Treatment with TTR tetramer stabilizers (tafamidis: approved in EU and select regions for treatment of the polyneuropathy of hATTR amyloidosis [16]; and diflunisal: used off-label for hATTR amyloidosis [6]) has been shown to slow progression of neurologic impairment [17, 18]. Here, TTR is linked to amyloidosis.